表紙
市場調查報告書

粘膜藥物輸送設備:醫療設備的開發平台評估

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 851183
出版日期 內容資訊 英文 221 Pages
訂單完成後即時交付
價格
粘膜藥物輸送設備:醫療設備的開發平台評估 Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年10月31日內容資訊: 英文 221 Pages
簡介

本報告提供全球粘膜藥物遞送設備市場上的主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,再彙整產品的功能·特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (業績報告·資本交易趨勢等) 等資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 粘膜藥物輸送設備概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 粘膜藥物輸送設備的企業:各臨床實驗階段的開發中產品
  • 粘膜藥物輸送設備:各臨床實驗階段的開發中產品

第5章 粘膜藥物輸送設備市場:企業·產品概要

  • AcelRx Pharmaceuticals Inc
  • Aegis Therapeutics LLC
  • AFYX Therapeutics A/S
  • Albert Einstein College of Medicine
  • Allergan Plc
  • Amphastar Pharmaceuticals Inc
  • Aquestive Therapeutics Inc
  • ARS Pharmaceuticals Inc
  • Auritec Pharmaceuticals Inc
  • BeFree!
  • Bespak Europe Ltd
  • Biorings LLC
  • BioXcel Therapeutics Inc
  • Callitas Therapeutics Inc
  • Columbia University
  • Combinent BioMedical Systems Inc
  • Conrad
  • Dare Bioscience Inc
  • Emergent BioSolutions Inc
  • Evestra Inc
  • Evofem Biosciences Inc
  • Evoke Pharma Inc
  • EyeGate Pharmaceuticals Inc
  • Ferring Pharmaceuticals AS
  • Ghent University
  • Glenmark Pharmaceuticals Ltd
  • Hebrew University of Jerusalem
  • INSYS Therapeutics Inc
  • IntelGenx Corp
  • Janssen Research & Development LLC
  • Karessa Pharma AB
  • Kytogenics Pharmaceuticals Inc
  • Laboratoire HRA Pharma SAS
  • Laboratorios Andromaco
  • Lyra Therapeutics
  • McNeil AB
  • Medlab Clinical Ltd
  • Merck & Co Inc
  • Merck Serono SA
  • Merck Sharp & Dohme Ltd
  • Mithra Pharmaceuticals SA
  • Mystic Pharmaceuticals Inc
  • Nanosys Inc
  • NorInvent AB
  • Novus Therapeutics Inc
  • Oak Crest Institute of Science
  • Opiant Pharmaceuticals Inc
  • OptiNose AS
  • Orion Biotechnology Canada Ltd
  • Orphanse Healthcare SAS
  • Palette Life Sciences AB
  • Phoenix Life Sciences International Ltd
  • Privo Technologies LLC
  • Promius Pharma LLC
  • RDD Pharma Ltd
  • Renown Pharma Ltd
  • Rhinomed Ltd
  • Scientus Pharma Inc
  • Shenox Pharmaceuticals LLC
  • 新日本科學
  • Suda Pharmaceuticals Ltd
  • Texas Tech University
  • The Hong Kong University of Science and Technology
  • Therakind Ltd
  • TherapeuticsMD Inc
  • Tiziana Life Sciences PLC
  • UCB SA
  • University of North Carolina at Chapel Hill
  • University of Pittsburgh
  • University of South Florida
  • University of Texas at Austin
  • University of the Witwatersrand
  • University of Washington
  • Washington University in St Louis

第6章 粘膜藥物輸送設備市場:目前的趨勢 (全10件)

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME1019EPD

GlobalData's Medical Devices sector report, "Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Transmucosal Drug Delivery Devicess pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transmucosal Drug Delivery device is intended for the localized delivery of medications through a mucous membrane. Usually, drugs are administered through buccal, rectal, vaginal, and nasal routes.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Transmucosal Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transmucosal Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transmucosal Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Transmucosal Drug Delivery Overview

3 Products under Development

  • 3.1 Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • 3.2 Transmucosal Drug Delivery - Pipeline Products by Segment
  • 3.3 Transmucosal Drug Delivery - Pipeline Products by Territory
  • 3.4 Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
  • 3.5 Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
  • 3.6 Transmucosal Drug Delivery - Ongoing Clinical Trials

4 Transmucosal Drug Delivery - Pipeline Products under Development by Companies

  • 4.1 Transmucosal Drug Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Transmucosal Drug Delivery - Pipeline Products by Stage of Development

5 Transmucosal Drug Delivery Companies and Product Overview

6 Transmucosal Drug Delivery- Recent Developments 1607 Appendix

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • Table 2: Transmucosal Drug Delivery - Pipeline Products by Segment
  • Table 3: Transmucosal Drug Delivery - Pipeline Products by Territory
  • Table 4: Transmucosal Dr

List of Figures

List of Figures

  • Figure 1: Transmucosal Drug Delivery - Pipeline Products by Stage of Development
  • Figure 2: Transmucosal Drug Delivery - Pipeline Products by Segment
  • Figure 3: Transmucosal Drug Delivery - Pipeline Products by Territory
  • Figure 4: Transmucosal Drug Delivery - Pipeline Products by Regulatory Path
  • Figure 5: Transmucosal Drug Delivery - Pipeline Products by Estimated Approval Date
  • Figure 6: Transmucosal Drug Delivery - Ongoing Clinical Trials